George Bickerstaff Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for George Bickerstaff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of George Bickerstaff. George Bickerstaff is a Director in ARIAD PHARMACEUTICALS INC ($ARIA) and a Director in VION PHARMACEUTICALS INC ($VION) and a Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and a Director in Innoviva, Inc. ($THRX) and a Director in CareDx, Inc. ($CDNA) and a Director in Axovant Sciences Ltd. ($AXON).
Address: C/O VION PHARMACEUTICALS, INC. 4 SCIENCE PARK NEW HAVEN 06511 CT
Companies in which George Bickerstaff is an Insider
ARIAD PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of George Bickerstaff: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 16 2017
$ARIA Market Capitalization: $4.64B
$ARIA Previous Close: $23.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CareDx, Inc.
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of George Bickerstaff: Director
Holdings: 71,538 shares
Current Value: $164,537
Latest Transaction: May 13 2021
$CDNA Market Capitalization: $50.00M
$CDNA Previous Close: $2.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Innoviva, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of George Bickerstaff: Director
Holdings: 104,560 shares
Latest Transaction: May 20 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INOVIO PHARMACEUTICALS, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of George Bickerstaff: Director
Holdings: 4,090 shares
Latest Transaction: Mar 22 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sio Gene Therapies Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of George Bickerstaff: Director
Holdings: 50,000 shares
Current Value: $648,500
Latest Transaction: Apr 17 2019
$AXON Market Capitalization: $1.28B
$AXON Previous Close: $12.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VION PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of George Bickerstaff: Director
Holdings: 9,683 shares
Latest Transaction: Dec 12 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of George Bickerstaff
Sentiment: All, ARIA, CDNA, THRX, GEB, AXON, VION
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2021 | THRX | Innoviva, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 17,482 | 0 | 104,560 | 87.1 K to 104.6 K (+20.08 %) |
| May 13 2021 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Sell | S | 63.75 | 600 | 38,248 | 70,938 | 71.5 K to 70.9 K (-0.84 %) |
| May 13 2021 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Sell | S | 63.03 | 9,400 | 592,499 | 71,538 | 80.9 K to 71.5 K (-11.61 %) |
| Apr 05 2021 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 193 | 0 | 80,938 | 80.7 K to 80.9 K (+0.24 %) |
| Dec 14 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Sell | S | 72.84 | 2,076 | 151,219 | 80,487 | 82.6 K to 80.5 K (-2.51 %) |
| Dec 14 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Sell | S | 72.04 | 3,224 | 232,248 | 82,563 | 85.8 K to 82.6 K (-3.76 %) |
| Dec 14 2020 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Sell | S | 71.10 | 4,700 | 334,177 | 85,787 | 90.5 K to 85.8 K (-5.19 %) |